A critical breakthrough in cancer investigation is emerging with the use of VHH fragments to reactivate mutated p53. This essential malignant inhibitor protein is frequently disabled in many types of malignancies, https://geniusbookmarks.com/story21924606/nanobodies-restore-p53-the-new-pathway-for-cancer-management